Academic Conference Project 2021
Academic Conference FERCIT and Network for Research Development in Thailand Year 2021
titled “Human Research Ethics in a New and Challenging Era”
in the form of Hybrid Conference (Onsite & Online)
Organized by the National Research Office (NRCT) in collaboration with the Human Research Ethics Club in Thailand
and the Sub-Committee on Promotion, Development and Driving Research Royal Thai Army Medical Department (Found.)
Date 18 – 20 August 2021,
Mongkut Vej Conference Room, 4th Floor, Phramongkutklao Witthaya Building
Phramongkutklao College of Medicine
By training in the form of Hybrid Conference (Onsite & Online)
principle and reason
At present, it is recognized that the advancement of various fields of science, especially in medical science, is due to research and partly depends on human research, interest, objectives in conducting research involving people to understand. Pathogenesis of disease, study of prevalence, incidence, development of prevention, diagnosis, treatment process. quality improvement medical treatment health promotion Improving the quality of life of patients In addition, conducting research in social sciences and humanities related to people Although there were no interventions that could cause harm to the volunteers. However, research studies using questionnaires, interviews or surveys may pose risks or impacts to subjects economically, socially, and mentally. can stigmatize the volunteers or the community
When conducting research involving people, the well-being and safety of the subjects is a priority. The potential risks to subjects in a research project are directly borne by the investigator. Researchers must protect the life, health, privacy and dignity of the subjects. Therefore, the researcher needs to have a good basic knowledge of the subject. Protecting volunteers (human subject protection)
In addition to that, many new drugs are currently being developed and in various forms of therapeutics. However, these studies have undergone pharmacological and toxicological studies in laboratory animals until there is evidence of efficacy and safety at pre-clinical levels. It needs to be studied in humans, which is an important step to prove. and confirmed its efficacy and safety in humans before the substance is considered for registration as a new drug. The period of time for research and development of new drugs is about 3 -15 years, making new drugs have a patent protection when they are released to the market for a short time. Drug R&D companies based in the US and Europe are more likely to conduct clinical trials outside of the drug developer’s country. because there are many volunteers and patients The study will be completed faster and cost less than doing the drug developer’s own country study. Currently, there are more clinical research studies in Thailand. And will increase more in the future because Thailand has factors and infrastructure that facilitate clinical research studies. If the quality of clinical trials is developed in line with the international standard “Good Clinical Practice (GCP)” that places great importance on the protection of the safety and well-being of the subjects.
